Abstract
Psoriasis is a common disease affecting approximately 2.5% of the UK population. It has been traditionally thought of as a chronic inflammatory skin disease, but recent research suggests that psoriasis is a disorder of systemic inflammation with chiefly cutaneous and joint manifestations. Several cardiometabolic manifestations of this systemic inflammatory process are now well recognised, including ischaemic heart disease,1,2 cerebrovascular accident,2 diabetes,3 hypercholesterolaemia,4 and hypertension.5 In addition patients with psoriasis have a higher incidence of smoking and obesity.6 In October 2012 the National Institute for Health and Care Excellence published a clinical guideline on psoriasis in which it recommends that every patient with psoriasis should have a cardiovascular risk assessment.7 We …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The British journal of general practice : the journal of the Royal College of General Practitioners
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
